Correlation Between Neurocrine Biosciences and Terns Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Neurocrine Biosciences and Terns Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neurocrine Biosciences and Terns Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Neurocrine Biosciences and Terns Pharmaceuticals, you can compare the effects of market volatilities on Neurocrine Biosciences and Terns Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neurocrine Biosciences with a short position of Terns Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neurocrine Biosciences and Terns Pharmaceuticals.
Diversification Opportunities for Neurocrine Biosciences and Terns Pharmaceuticals
-0.39 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Neurocrine and Terns is -0.39. Overlapping area represents the amount of risk that can be diversified away by holding Neurocrine Biosciences and Terns Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Terns Pharmaceuticals and Neurocrine Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neurocrine Biosciences are associated (or correlated) with Terns Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Terns Pharmaceuticals has no effect on the direction of Neurocrine Biosciences i.e., Neurocrine Biosciences and Terns Pharmaceuticals go up and down completely randomly.
Pair Corralation between Neurocrine Biosciences and Terns Pharmaceuticals
Given the investment horizon of 90 days Neurocrine Biosciences is expected to under-perform the Terns Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, Neurocrine Biosciences is 2.15 times less risky than Terns Pharmaceuticals. The stock trades about -0.01 of its potential returns per unit of risk. The Terns Pharmaceuticals is currently generating about 0.0 of returns per unit of risk over similar time horizon. If you would invest 796.00 in Terns Pharmaceuticals on September 14, 2024 and sell it today you would lose (137.00) from holding Terns Pharmaceuticals or give up 17.21% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Neurocrine Biosciences vs. Terns Pharmaceuticals
Performance |
| Timeline |
| Neurocrine Biosciences |
| Terns Pharmaceuticals |
Neurocrine Biosciences and Terns Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Neurocrine Biosciences and Terns Pharmaceuticals
The main advantage of trading using opposite Neurocrine Biosciences and Terns Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neurocrine Biosciences position performs unexpectedly, Terns Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Terns Pharmaceuticals will offset losses from the drop in Terns Pharmaceuticals' long position.| Neurocrine Biosciences vs. Puma Biotechnology | Neurocrine Biosciences vs. Iovance Biotherapeutics | Neurocrine Biosciences vs. Day One Biopharmaceuticals | Neurocrine Biosciences vs. Inozyme Pharma |
| Terns Pharmaceuticals vs. Amylyx Pharmaceuticals | Terns Pharmaceuticals vs. Acumen Pharmaceuticals | Terns Pharmaceuticals vs. Inozyme Pharma | Terns Pharmaceuticals vs. X4 Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Complementary Tools
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |